Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
137,8 USD | -0,87% | +3,94% | +4,55% |
Omzet 2024 * | 2,21 mld. 2,06 mld. | Omzet 2025 * | 2,52 mld. 2,35 mld. | Marktkapitalisatie | 13,86 mld. 12,9 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 490 mln. 456 mln. | Nettowinst (verlies) 2025 * | 666 mln. 620 mln. | EV/omzet 2024 * | 5,32 x |
Nettoliquiditeiten 2024 * | 2,09 mld. 1,95 mld. | Nettoliquiditeiten 2025 * | 2,88 mld. 2,68 mld. | EV/omzet 2025 * | 4,36 x |
K/w-verhouding 2024 * |
29,2
x | K/w-verhouding 2025 * |
21,6
x | Werknemers | 1.400 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,73% |
Recentste transcriptie over Neurocrine Biosciences, Inc.
1 dag | -0,87% | ||
1 week | +3,94% | ||
Lopende maand | -0,12% | ||
1 maand | -1,78% | ||
3 maanden | -2,30% | ||
6 maanden | +27,28% | ||
Lopend jaar | +4,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Director of Finance/CFO | 44 | 01-11-17 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30-11-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01-04-99 |
George Morrow
BRD | Director/Board Member | 72 | 01-10-15 |
Kevin Gorman
FOU | Founder | 66 | 01-01-92 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
13.65% | 215 M€ | +12,27% | - | |
3.81% | 1 M€ | 0,00% | - | |
1.85% | 8 M€ | +2,44% | ||
1.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 137,8 | -0,87% | 735 781 |
24-04-24 | 139 | -0,80% | 927 988 |
23-04-24 | 140,1 | +4,81% | 1 607 818 |
22-04-24 | 133,7 | +1,26% | 575 067 |
19-04-24 | 132 | -0,41% | 556 303 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,55% | 13,86 mld. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,52% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-8,70% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+32,11% | 12,04 mld. | |
-26,18% | 8,08 mld. |